Table 4 |
||||
|
Factors associated with full publication. |
||||
|
Variable |
Unadjusted Odds Ratio (95% CI) |
p-value |
Adjusted Odds Ratio (95% CI) |
p-value |
|
|
||||
|
Meeting (vs. NKF) |
||||
|
ASN |
2.87 (1.60, 5.15) |
0.0003 |
2.34 (1.27, 4.34) |
0.039 |
|
ERA-EDTA |
1.92 (1.07, 3.45) |
0.028 |
1.86 (1.03, 3.34) |
0.007 |
|
|
||||
|
Basic science research (vs. clinical research) |
2.84 (1.44, 5.61) |
0.002 |
2.15 (1.05, 4.43) |
0.04 |
|
|
||||
|
Collaborative study (vs. non-collaborative study) |
1.97 (0.41, 1.04) |
0.097 |
--- |
--- |
|
|
||||
|
Industry sponsorship (vs. no industry sponsorship) |
1.44 (0.76, 2.71) |
0.252 |
--- |
--- |
|
|
||||
|
Multi-center study (vs. single-center study) |
1.33 (0.83, 2.13) |
0.227 |
---- |
---- |
|
|
||||
|
Randomized control and cohort trials (vs. other study designs) |
0.85 (0.54, 1.35) |
0.497 |
--- |
--- |
|
|
||||
|
American center (vs. non-American center) |
0.64 (0.40, 1.02) |
0.067 |
--- |
--- |
|
|
||||
|
Harel et al. International Archives of Medicine 2011 4:40 doi:10.1186/1755-7682-4-40 |
||||
